Significant opportunities in the cancer metabolism-based therapeutics market include leveraging precision medicine to target unique cancer cell metabolic pathways, driving personalized treatment ...

A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

In the world of drug repositioning metformin has a prominent place. This anti-diabetic medication which belongs to the family of biguanides has been prescribed for more than 60 years in Europe.

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...

A new study has demonstrated that colon cancer cells may change identity to metastasize. Loss of GATA6, a transcription factor that controls which genes are turned on or off, can reprogram colorectal ...